Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials

The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a number of brain diseases.

Gina Kolata
Author: Gina Kolata

Written by

Gina Kolata

in

Clinical Trials, GLP-1 RAs (Drug), Novo Nordisk A/S, Research
←Zelenskyy Responds To Trump’s Meltdown Over Ukraine Showing ‘Zero Gratitude’ For U.S. Support
Letitia James ‘Heartened’ After Judge Dismisses DOJ Lawsuit Against Her→

More posts

  • Brie and Nikki Bella Hot Shots To Celebrate Their 43rd Birthday!

  • Trump’s grip on GOP tested as MAGA allies head for exit

  • At least 24 dead in Nigeria when boat going to funeral capsizes

  • Kaitlan Collins Notes ‘Real Time’ Absence Was Due To White House Press Conference

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube